September 2026– date –
-
New Technology
Precision Fermentation: Imperial College London land use study
My Modern Met UK Overview A new study by Imperial College London indicates that cow-free milk produced via precision fermentation could require up to 96% less land compared to conventional dairy farming. Precision fermentation is an inno... -
Market Trends
Multifors 3: INFORS HT 23-day perfusion culture specs
INFORS HT Switzerland Overview INFORS HT has published an application note detailing the successful 23-day long-term perfusion culture of NIST CHO cells using its Multifors 3 benchtop bioreactor. The study proves the Multifors 3's suitab... -
New Technology
AI Bioreactors: Novonesis and ISU enzyme production explained
megaproject.com USA Overview Iowa State University (ISU) and Novonesis, with funding from BioMADE, have developed AI-powered bioreactors featuring a machine learning framework. This innovative technology enables real-time monitoring and ... -
Business Trends
Formo: FDA timeline for precision fermentation casein in 2026
Dairy Reporter Germany Overview German startup Formo is expected to receive a 'No Questions Letter' from the U.S. FDA regarding its GRAS assessment for precision-fermented casein within weeks, signaling its readiness for U.S. market entr... -
Market Trends
FDA vs. EMA: CGT manufacturing GMP specs and 2026 differences
Rhizome AI USA Overview The FDA and EMA employ distinct strategies for manufacturing controls and GMP requirements for cell and gene therapy (CGT) products at the Investigational New Drug (IND)/Clinical Trial Application (CTA) stage. The... -
Market Trends
Viral Vectors: Wave-mixed vs stirred-tank bioreactor specs
BioProcess Tools USA Overview A comparative analysis of bioreactor platforms for viral vector manufacturing reveals distinct advantages: wave-mixed bioreactors, offering low shear, are ideal for shear-sensitive lentivirus, T-cell expansi... -
New Technology
CYBORGEL: UC Davis $36.5M ARPA-H cell therapy storage timeline
University of California, Davis USA Overview The UC Davis-led CYBORGEL project has been awarded up to $36.5 million in ARPA-H funding to pioneer room-temperature storage solutions for cellular therapies. This initiative aims to drastical... -
New Technology
CAR-T/NK cells: Immunomodulatory expansion and 2026 regulatorys
Frontiers Switzerland Overview A recent academic review details advanced immunomodulatory strategies poised to significantly enhance ex vivo immune cell expansion for adoptive cell therapies, including CAR-T and NK cells. The paper syste... -
Business Trends
OXGENE: Minaris and Asimov AAV cell line manufacturing roadmap
PharmaSource USA Overview Minaris and Asimov have partnered to develop superior producer cell lines for AAV gene therapy manufacturing, combining Minaris' OXGENE viral vector technology with Asimov's synthetic biology platform. This coll... -
Market Trends
I Peace: Clinical-grade iPSC mass production specs for 2026
BioInformant USA Overview I Peace has developed a fully-closed automated manufacturing system capable of mass-producing clinical-grade induced pluripotent stem cell (iPSC) lines, successfully meeting stringent FDA and PMDA safety standar...